FcγRIIb Exacerbates LPS-Induced Neuroinflammation by Binding with the Bridging Protein DAP12 and Promoting the Activation of PI3K/AKT Signaling Pathway in Microglia
YingWen Han,Luyao Wang,Xiaokun Ye,Xue Gong,Xiaoyi Shao
DOI: https://doi.org/10.2147/jir.s428093
IF: 4.5
2024-01-04
Journal of Inflammation Research
Abstract:YingWen Han, &ast Luyao Wang, &ast Xiaokun Ye, Xue Gong, Xiaoyi Shao Department of Immunology, Medical School, Nantong University, Nantong, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoyi Shao, Department of Immunology, Medical School, Nantong University, 19 Qixiu Road, Nantong, Jiangsu, 226001, People's Republic of China, Email Introduction: This paper focuses on the expression and role of FcγRIIb in neuroinflammation, exploring the molecular mechanisms by which FcγRIIb interacts with the bridging protein DAP12 to regulate the PI3K-AKT signaling pathway that promote neuroinflammation and aggravate neuronal injury. Methods: LPS-induced neuroinflammation models in vivo and in vitro were constructed to explore the role and mechanism of FcγRIIb in CNS inflammation. Subsequently, FcγRIIb was knocked down or overexpressed to observe the activation of BV2 cell and the effect on PI3K-AKT pathway. Then the PI3K-AKT pathway was blocked to observe its effect on cell activation and FcγRIIb expression. We analyzed the interaction between FcγRIIb and DAP12 by Immunoprecipitation technique. Then FcγRIIb was overexpressed while knocking down DAP12 to observe its effect on PI3K-AKT pathway. Finally, BV2 cell culture supernatant was co-cultured with neuronal cell HT22 to observe its effect on neuronal apoptosis and cell activity. Results: In vivo and in vitro, we found that FcγRIIb expression was significantly increased and activated the PI3K-AKT pathway. Contrary to the results of overexpression of FcγRIIb, knockdown of FcγRIIb resulted in a significant low level of relevant inflammatory factors and suppressed the PI3K-AKT pathway. Furthermore, LPS stimulation induced an interaction between FcγRIIb and DAP12. Knockdown of DAP12 suppressed inflammation and activation of the PI3K-AKT pathway in BV2 cells, and meantime overexpression of FcγRIIb suppressed the level of FcγRIIb-induced AKT phosphorylation. Additionally, knockdown of FcγRIIb inhibited microglia activation, which induced neuronal apoptosis. Discussion: Altogether, our experiments indicate that FcγRIIb interacts with DAP12 to promote microglia activation by activating the PI3K-AKT pathway while leading to neuronal apoptosis and exacerbating brain tissue injury, which may provide a new target for the treatment of inflammatory diseases in the central nervous system. Keywords: LPS-induced neuroinflammation, FcγRIIb, DAP12, microglia, PI3K-AKT Neuroinflammation is defined as an inflammatory response that occurs within the central nervous system (CNS). The progression of neuroinflammation is characterized by a complex cascade of cellular and biomolecular reactions, with brain triggering a nonspecific immune response upon stimulation. 1–3 Common abnormal features in the brains of patients with neuroinflammation include increased expression of pro-inflammatory factors, macrophage activation, peripheral leukocyte infiltration, and damage to neural tissue. Various glial cells are present in the human brain, among which, microglia play a key role in neuroinflammation. In the normal brain environment, microglia are branched and highly motile, and they serve to monitor fluctuations in the brain microenvironment, removing apoptotic neurons and maintaining the stability of the central nervous system. 4–6 Microglia are activated and polarized into the proinflammatory phenotype or the anti-inflammatory phenotype; 7–9 the proinflammatory phenotype secrete large amounts of inflammatory and neurotoxic factors, which exacerbate neuronal damage, while the anti-inflammatory phenotype secrete large amounts of anti-inflammatory and trophic factors upon activation, alleviating inflammation and maintaining the stability of the brain internal environment. 10,11 FcγRIIb, a glycoprotein of approximately 40 kDa, consists of two IgG-like extracellular domains, a transmembrane region, and a cytoplasmic tail containing (immunoreceptor tyrosine-based inhibition motif), and it is the only IgG-inhibitory Fc receptor known to be found in both humans and mice. Many of the typical functions of FcγRIIb are based on signaling through the cytoplasmic region ITIM. 12–15 FcγRIIb is a potent modulator in lupus nephritis, while in arthritis models, it effectively attenuates collagen-induced arthritis symptoms. Although ITIM-mediated inhibition through the cytoplasmic compartment is thought to be the main feature of FcγRIIb-mediated immune regulation, evidence also suggests that inhibition or activation of immune responses can occur independently of ITIM signaling in some specific cases. Following a review of the literature, we found reports indicating a 3.54-fold increase -Abstract Truncated-
immunology